dimethyl 2,6-dimethyl-4-(1-methyl-1H-indazol-5-yl)-1,4-dihydropyridine-3,5-dicarboxylate

ID: ALA5194762

PubChem CID: 168285038

Max Phase: Preclinical

Molecular Formula: C19H21N3O4

Molecular Weight: 355.39

Names and Identifiers

Canonical SMILES:  COC(=O)C1=C(C)NC(C)=C(C(=O)OC)C1c1ccc2c(cnn2C)c1

Standard InChI:  InChI=1S/C19H21N3O4/c1-10-15(18(23)25-4)17(16(11(2)21-10)19(24)26-5)12-6-7-14-13(8-12)9-20-22(14)3/h6-9,17,21H,1-5H3

Standard InChI Key:  CCIZLNJTQPBDJE-UHFFFAOYSA-N

Molfile:  

 
     RDKit          2D

 26 28  0  0  0  0  0  0  0  0999 V2000
   -0.7120    2.3583    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -0.7120    1.5333    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -0.0000    1.1250    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.7119    1.5333    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.7119    2.3583    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -0.0000    2.7750    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
   -0.0004    0.3008    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -0.7165   -0.1110    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -0.7169   -0.9352    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.7117   -0.1088    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -1.4259    1.1197    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -2.1409    1.5312    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
   -2.8548    1.1178    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -1.4247    0.2948    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
   -1.4277    2.7687    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    1.4276    2.7687    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    1.4258    1.1197    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    1.4246    0.2948    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    2.1409    1.5312    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    2.8548    1.1178    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.7149   -0.9315    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0013   -1.3501    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.1788   -2.1582    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    1.0022   -2.2390    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    1.3334   -1.4810    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -0.3690   -2.7750    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
  1  2  2  0
  2  3  1  0
  3  4  1  0
  4  5  2  0
  1  6  1  0
  5  6  1  0
  3  7  1  0
  7  8  2  0
  8  9  1  0
 10  7  1  0
  2 11  1  0
 11 12  1  0
 12 13  1  0
 11 14  2  0
  1 15  1  0
  5 16  1  0
  4 17  1  0
 17 18  2  0
 17 19  1  0
 19 20  1  0
 21 10  2  0
  9 22  2  0
 21 22  1  0
 22 23  1  0
 23 24  1  0
 24 25  2  0
 25 21  1  0
 23 26  1  0
M  END

Alternative Forms

1. Parent:

   

   ALA5194762

   ---

Molecule Features

Natural Product: No

Oral: No

Chemical Probe: No

Parenteral: No

Molecule Type:

Topical: No

First In Class: No

Black Box: No

Chirality: No

Availability: No

Prodrug: No

Calculated Properties

Molecular Weight: 355.39

Molecular Weight (Monoisotopic): 355.1532

AlogP: 2.15

#Rotatable Bonds: 3

Polar Surface Area: 82.45

Molecular Species: NEUTRAL

HBA: 7

HBD: 1

#RO5 Violations: ┄

HBA (Lipinski): 7

HBD (Lipinski): 1

#RO5 Violations (Lipinski): ┄

CX Acidic pKa: ┄

CX Basic pKa: 1.21

CX LogP: 1.32

CX LogD: 1.32

Aromatic Rings: 2

Heavy Atoms: 26

QED Weighted: 0.85

Np Likeness Score: -0.81

References

1. Huang MX, Tian YJ, Han C, Liu RD, Xie X, Yuan Y, Yang YY, Li Z, Chen J, Luo HB, Wu Y..  (2022)  Structural Modifications of Nimodipine Lead to Novel PDE1 Inhibitors with Anti-pulmonary Fibrosis Effects.,  65  (12.0): [PMID:35666471] [10.1021/acs.jmedchem.2c00458]

Source

Source(1):

• Scientific Literature